NMDARs in neurological diseases: a potential therapeutic target.

NMDARs in neurological diseases: a potential therapeutic target.

Item
http://www.wikidata.org/entity/Q38232734
Impact of Increased Astrocyte Expression of IL-6, CCL2 or CXCL10 in Transgenic Mice on Hippocampal Synaptic FunctionGlia and TRPM2 Channels in Plasticity of Central Nervous System and Alzheimer's DiseasesPrediction of N-Methyl-D-Aspartate Receptor GluN1-Ligand Binding Affinity by a Novel SVM-Pose/SVM-Score Combinatorial Ensemble Docking SchemeNew Insights into the Crosstalk between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases.Light-induced regulation of ligand-gated channel activity.Synthesis and Biological Evaluation of Novel Multi-target-Directed Benzazepines Against Excitotoxicity.Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.Inhibitory effects of imidazoline receptor ligands on basal and kainic acid-induced neurotoxic signalling in mice.
P2860

NMDARs in neurological diseases: a potential therapeutic target.

Item
http://www.wikidata.org/entity/Q38232734
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
NMDARs in neurological diseases: a potential therapeutic target.
@en
type
label
NMDARs in neurological diseases: a potential therapeutic target.
@en
prefLabel
NMDARs in neurological diseases: a potential therapeutic target.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
NMDARs in neurological diseases: a potential therapeutic target.
@en
P2093
P2860
P304
P31
P356
10.3109/00207454.2014.940941
P433
P478
P50
P577
P5875
P698